Immediate Impact
1 by Nobel laureates 2 from Science/Nature 50 standout
Citing Papers
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Works of Takeo Shibata being referenced
The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Takeo Shibata | 94 | 95 | 39 | 93 | 36 | 341 | |
| E. Sanna | 96 | 51 | 38 | 48 | 34 | 401 | |
| R D'Amelio | 95 | 115 | 13 | 49 | 33 | 352 | |
| Kubilay Ertan | 56 | 98 | 86 | 83 | 27 | 389 | |
| Branka Užarević | 43 | 95 | 62 | 67 | 27 | 319 | |
| Chang‐Suk Kang | 83 | 38 | 21 | 97 | 27 | 363 | |
| U Datta | 107 | 44 | 13 | 37 | 36 | 338 | |
| Mansour Moghimi | 99 | 62 | 17 | 54 | 49 | 350 | |
| I Janatková | 63 | 147 | 5 | 75 | 32 | 401 | |
| Eric McLaughlin | 47 | 64 | 22 | 112 | 59 | 378 | |
| J. Greally | 63 | 156 | 11 | 53 | 39 | 392 |
All Works
Login with ORCID to disown or claim papers
Loading papers...